70 related articles for article (PubMed ID: 38686044)
21. The emerging roles of circRNAs in cancer and oncology.
Kristensen LS; Jakobsen T; Hager H; Kjems J
Nat Rev Clin Oncol; 2022 Mar; 19(3):188-206. PubMed ID: 34912049
[TBL] [Abstract][Full Text] [Related]
22. Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma.
Chai P; Jia R; Li Y; Zhou C; Gu X; Yang L; Shi H; Tian H; Lin H; Yu J; Zhuang A; Ge S; Jia R; Fan X
Prog Retin Eye Res; 2022 Jul; 89():101030. PubMed ID: 34861419
[TBL] [Abstract][Full Text] [Related]
23. Circ-GALNT16 restrains colorectal cancer progression by enhancing the SUMOylation of hnRNPK.
Peng C; Tan Y; Yang P; Jin K; Zhang C; Peng W; Wang L; Zhou J; Chen R; Wang T; Jin C; Ji J; Feng Y; Tang J; Sun Y
J Exp Clin Cancer Res; 2021 Aug; 40(1):272. PubMed ID: 34452628
[TBL] [Abstract][Full Text] [Related]
24. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
Paramasivam A; George R; Priyadharsini JV
Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
[TBL] [Abstract][Full Text] [Related]
25. CircPTPRA blocks the recognition of RNA N
Xie F; Huang C; Liu F; Zhang H; Xiao X; Sun J; Zhang X; Jiang G
Mol Cancer; 2021 Apr; 20(1):68. PubMed ID: 33853613
[TBL] [Abstract][Full Text] [Related]
26. Circ_0119872 promotes uveal melanoma development by regulating the miR-622/G3BP1 axis and downstream signalling pathways.
Liu S; Chen L; Chen H; Xu K; Peng X; Zhang M
J Exp Clin Cancer Res; 2021 Feb; 40(1):66. PubMed ID: 33579337
[TBL] [Abstract][Full Text] [Related]
27. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity.
Li B; Zhu L; Lu C; Wang C; Wang H; Jin H; Ma X; Cheng Z; Yu C; Wang S; Zuo Q; Zhou Y; Wang J; Yang C; Lv Y; Jiang L; Qin W
Nat Commun; 2021 Jan; 12(1):295. PubMed ID: 33436560
[TBL] [Abstract][Full Text] [Related]
28. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
[TBL] [Abstract][Full Text] [Related]
29.
Gu Y; Niu S; Wang Y; Duan L; Pan Y; Tong Z; Zhang X; Yang Z; Peng B; Wang X; Han X; Li Y; Cheng T; Liu Y; Shang L; Liu T; Yang X; Sun M; Jiang S; Zhang C; Zhang N; Ye Q; Gao S
Cancer Res; 2021 Feb; 81(4):923-934. PubMed ID: 33293428
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation.
Zeng Z; Xia L; Fan S; Zheng J; Qin J; Fan X; Liu Y; Tao J; Liu Y; Li K; Ling Z; Bu Y; Martin KA; Hwa J; Liu R; Tang WH
Circulation; 2021 Jan; 143(4):354-371. PubMed ID: 33207953
[TBL] [Abstract][Full Text] [Related]
31. RNA in cancer.
Goodall GJ; Wickramasinghe VO
Nat Rev Cancer; 2021 Jan; 21(1):22-36. PubMed ID: 33082563
[TBL] [Abstract][Full Text] [Related]
32. The prognostic values of m6A RNA methylation regulators in uveal melanoma.
Tang J; Wan Q; Lu J
BMC Cancer; 2020 Jul; 20(1):674. PubMed ID: 32682400
[TBL] [Abstract][Full Text] [Related]
33. ERK-Mediated Mechanochemical Waves Direct Collective Cell Polarization.
Hino N; Rossetti L; Marín-Llauradó A; Aoki K; Trepat X; Matsuda M; Hirashima T
Dev Cell; 2020 Jun; 53(6):646-660.e8. PubMed ID: 32497487
[TBL] [Abstract][Full Text] [Related]
34. N
Li Z; Peng Y; Li J; Chen Z; Chen F; Tu J; Lin S; Wang H
Nat Commun; 2020 May; 11(1):2578. PubMed ID: 32444598
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness.
Lu H; Xie Y; Tran L; Lan J; Yang Y; Murugan NL; Wang R; Wang YJ; Semenza GL
J Clin Invest; 2020 Sep; 130(9):4607-4623. PubMed ID: 32427586
[TBL] [Abstract][Full Text] [Related]
36. Uveal melanoma.
Jager MJ; Shields CL; Cebulla CM; Abdel-Rahman MH; Grossniklaus HE; Stern MH; Carvajal RD; Belfort RN; Jia R; Shields JA; Damato BE
Nat Rev Dis Primers; 2020 Apr; 6(1):24. PubMed ID: 32273508
[TBL] [Abstract][Full Text] [Related]
37. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
[TBL] [Abstract][Full Text] [Related]
38. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
39. m
Jia R; Chai P; Wang S; Sun B; Xu Y; Yang Y; Ge S; Jia R; Yang YG; Fan X
Mol Cancer; 2019 Nov; 18(1):161. PubMed ID: 31722709
[TBL] [Abstract][Full Text] [Related]
40. Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer.
Ma G; Liang Y; Chen Y; Wang L; Li D; Liang Z; Wang X; Tian D; Yang X; Niu H
Mol Cancer Res; 2020 Feb; 18(2):324-339. PubMed ID: 31672701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
